LYN, a tyrosine kinase, is integral to internal signaling processes and is crucial for the differentiation and persistence of the leukemic phenotype across various blood cancers including AML, CML, and B-cell lymphocytic leukemia [52]. The gene discussed is LYN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.